Innovation in New Drug Approvals of 2019 Advances Patient Care Across a Broad Range of Diseases

In 2019, the FDA approved a wide variety of new drugs never before marketed in the United States, known as "novel" drugs, along with a range of new approvals containing active ingredients already on the market put to new and innovative uses.

Source: FDA Center for Drug Evaluation and Research - What's New - January 6, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news